Association of Helicobacter pylori infection with diabetic complications: A meta-analysis

Endocrine Research

Volumn 39, Issue 1, 2014, Pages 7-12

  Wang, Feng ^a   Fu, Yakun ^b   Lv, Zongshun ^b  

^a TIANJIN PEOPLE'S HOSPITAL   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Ischemic heart disease; Literature search; Nephropathy; Neuropathy; Relevant risk estimate; Retinopathy

Indexed keywords

ARTICLE; DIABETES MELLITUS; DISEASE ASSOCIATION; HELICOBACTER INFECTION; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; META ANALYSIS; NEUROPATHY; NONHUMAN; PRIORITY JOURNAL; RETINOPATHY; RISK ASSESSMENT;

DIABETES COMPLICATIONS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS;

EID: 84892769604     PISSN: 07435800     EISSN: None     Source Type: Journal    
DOI: 10.3109/07435800.2013.794426     Document Type: Article

References (33)

1. Bener A, Uduman SA, Ameen A, et al. Prevalence of Helicobacter pylori infection among low socio-economic workers. J Commun Dis 2002;34: 179-84.
2. Das JC, Paul N. Epidemiology and pathophysiology of Helicobacter pylori infection in children. Indian J Pediatr 2007;74: 287-90.
3. Khalifa MM, Sharaf RR, Aziz RK. Helicobacter pylori: a poor man's gut pathogen? Gut Pathogens 2010;2:2.
4. IARC Working group on the evaluation of the carcinogenic risks to humans. Helicobacter pylori. Schistosomes, liver flukes and helicobacter pylori; views and expert opinions of an IARC working group on the evaluation of carcinogenic risks to humans. Lyon IARC 1994;61: 177-240.
5. Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, et al. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991;338: 1175-6.
6. Bytzer P, Talley NJ, Hammer J, et al. GI symptoms in diabetes mellitus are associated with both poor glycemic control and diabetic complications. Am J Gastroenterol 2002;97: 604-11.
7. Bytzer P, Talley NJ, Leemon M, et al. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Intern Med 2001;161: 1989-96.
8. Talley NJ, Howell S, Jones MP, et al. Predictors of turnover of lower gastrointestinal symptoms in diabetes mellitus. Am J Gastroenterol 2002;97: 3087-94.
9. Clarke M, Horton R. Bringing it all together: lancet - cochrane collaborate on systematic reviews. Lancet 2001;357:1728.
10. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283: 2008-12.
11. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315: 629-34.
12. Egger M, Smith GD. Misleading meta-analysis. BMJ 1995;311: 753-4.
13. Athanasiou T, Al-Ruzzeh S, Kumar P, et al. Off-pump myocardial revascularization is associated with less incidence of stroke in elderly patients. Ann Thorac Surg 2004;77: 745-53.
14. Agrawal RP, Sharma R, Garg D, et al. Role of Helicobacter pylori in causation of diabetic gastropathies and non-gastrointestinal complications in type 2 diabetes. J Indian Med Assoc 2010;108: 140-3.
15. Schimke K, Chubb SA, Davis WA, et al. Helicobacter pylori cytotoxin- associated gene-A antibodies do not predict complications or death in type 2 diabetes: the Fremantle Diabetes Study. Atherosclerosis 2010;212: 321-6.
16. Ohnishi M, Fukui M, Ishikawa T, et al. Helicobacter pylori infection and arterial stiffness in patients with type 2 diabetes mellitus. Metabolism 2008;57: 1760-4.
17. Hamed SA, Amine NF, Galal GM, et al. Vascular risks and complications in diabetes mellitus: the role of helicobacter pylori infection. J Stroke Cerebrovasc Dis 2008;17: 86-94.
18. Demir M, Gokturk HS, Ozturk NA, et al. Helicobacter pylori prevalence in diabetes mellitus patients with dyspeptic symptoms and its relationship to glycemic control and late complications. Dig Dis Sci 2008;53: 2646-9.
19. Gulcelik NE, Kaya E, Demirbas B, et al. Helicobacter pylori prevalence in diabetic patients and its relationship with dyspepsia and autonomic neuropathy. J Endocrinol Invest 2005;28: 214-17.
20. Ongey M, Brenner H, Thefeld W, et al. Helicobacter pylori and hepatitis A virus infections and the cardiovascular risk profile in patients with diabetes mellitus: results of a population-based study. Eur J Cardiovasc Prev Rehabil 2004;11: 471-6.
21. de Luis DA, Lahera M, Cantón R, et al. Association of Helicobacter pylori infection with cardiovascular and cerebrovascular disease in diabetic patients. Diabetes Care 1998;21: 1129-32.
22. Ito Y, Azuma T, Ito S, et al. Analysis and typing of the vacA gene from cagA-positive strains of Helicobacter pylori isolated in Japan. J Clin Microbiol 1997;35: 1710-14.
23. Covacci A, Censini S, Bugnoli M, et al. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci USA 1993;90: 5791-5.
24. Atherton JC, Cao P, Peek Jr. RM, et al. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori: association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 1995;270: 17771-7.
25. Blaser MJ, Perez-Perez GI, Kleanthous H, et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995;55: 2111-15.
26. Banatvala N, Mayo K, Megraud F, et al. The cohort effect and Helicobacter pylori. J Infect Dis 1993;168: 219-21.
27. Kosunen TU, Aromaa A, Knekt P, et al. Helicobacter antibodies in 1973 and 1994 in the adult population of Vammala, Finland. Epidemiol Infect 1997;119: 29-34.
28. McMahon MM, Bistrian BR. Host defenses and susceptibility to infection in patients with diabetes mellitus. Infect Dis Clin North Am 1995;9: 1-9.
29. Pankewycz OG, Guan JX, Benedict JF. Cytokines as mediators of autoimmune diabetes and diabetic complications. Endocr Rev 1995;16: 164-76.
30. Ameriso SF, Fridman EA, Leiguarda RC, et al. Detection of Helicobacter pylori in human carotid atherosclerotic plaques. Stroke 2001;32: 385-91.
31. Franceschi F, Sepulveda AR, Gasbarrini A, et al. Cross-reactivity of anti-Cag A antibodies with vascular wall antigens: possible pathogenetic link between Helicobacter pylori infection and atherosclerosis. Circulation 2002;106: 430-4.
32. Loscalzo J. Lipoprotein (a): a unique risk factor for atherothrombotic disease. Arteriosclerosis 1990;10: 672-9.
33. Kratnov AE, Pavlov ON. Helicobacter pylori infection and state of antioxidant protection in patients with the unstable course of ischemic disease. Eksp Klin Gastroenterol 2004;145: 4-9.